Publications by authors named "Morgan Mace"

Claim this Profile
D
Direct Clinical Pharmacist-Patient Telephone Follow-Up: A Focus on GI Medical Oncology Symptom Management.
Jane E Rogers, Jennifer Zadlo, Cheuk Hong Leung, Van Nguyen, Michael Leung, Morgan Mace

JCO Oncol Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies.
Courtney D DiNardo, Caitlin R Rausch, Christopher Benton, Tapan Kadia, Nitin Jain, Morgan Mace

Am J Hematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib for treatment of B-cell malignancies.
Bryan Do, Morgan Mace, Amber Rexwinkle

Am J Health Syst Pharm· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
Morgan L Mace, Jenny Dahl, Elias J Jabbour

Expert Opin Pharmacother· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital.
Jack L Watkins, Karen R Eckmann, Morgan L Mace, Jane Rogers, Ginger Langley

P T· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis